The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Efficacy, Safety, and Tolerability, of EN3835 vs Placebo in the Treatment of Plantar Fibromatosis
Official Title: Phase 2, Double-blind, Randomized, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of EN3835 vs Placebo in the Treatment of Plantar Fibromatosis
Study ID: NCT05152173
Brief Summary: This randomized, double-blind, placebo-controlled study will evaluate the efficacy and safety of up to 2 treatments of EN3835 vs placebo in participants with plantar fibromatosis.
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Endo Clinical Trial Site #29, Mesa, Arizona, United States
Endo Clinical Trial Site #42, Tucson, Arizona, United States
Endo Clinical Trial Site #15, Bakersfield, California, United States
Endo Clinical Trial Site #41, Encinitas, California, United States
Endo Clinical Trial Site #9, Fresno, California, United States
Endo Clinical Trial Site #27, La Mesa, California, United States
Endo Clinical Trial Site #30, Los Angeles, California, United States
Endo Clinical Trial Site #12, Tarzana, California, United States
Endo Clinical Trial Site #36, Torrance, California, United States
Endo Clinical Trial Site #22, Vista, California, United States
Endo Clinical Trial Site #13, Whittier, California, United States
Endo Clinical Trial Site #16, Atlantis, Florida, United States
Endo Clinical Trial Site #43, Jacksonville, Florida, United States
Endo Clinical Trial Site #40, Miami, Florida, United States
Endo Clinical Trial Site #10, Pinellas Park, Florida, United States
Endo Clinical Trial Site #3, South Miami, Florida, United States
Endo Clinical Trial Site #14, Sweetwater, Florida, United States
Endo Clinical Trial Site #38, Lawrenceville, Georgia, United States
Endo Clinical Trial Site #31, Meridian, Idaho, United States
Endo Clinical Trial Site #32, Decatur, Illinois, United States
Endo Clinical Trial Site #19, O'Fallon, Illinois, United States
Endo Clinical Trial Site #33, Springfield, Illinois, United States
Endo Clinical Trial Site #23, Pasadena, Maryland, United States
Endo Clinical Trial Site #28, Jefferson City, Missouri, United States
Endo Clinical Trial Site #20, Las Vegas, Nevada, United States
Endo Clinical Trial Site #34, Oklahoma City, Oklahoma, United States
Endo Clinical Trial Site #4, York, Pennsylvania, United States
Endo Clinical Trial Site #35, Arlington, Texas, United States
Endo Clinical Trial Site #5, Bedford, Texas, United States
Endo Clinical Trial Site #24, Cedar Park, Texas, United States
Endo Clinical Trial Site #17, Dallas, Texas, United States
Endo Clinical Trial Site #2, Dallas, Texas, United States
Endo Clinical Trial Site #7, Fort Worth, Texas, United States
Endo Clinical Trial Site #39, Georgetown, Texas, United States
Endo Clinical Trial Site #25, Houston, Texas, United States
Endo Clinical Trial Site #8, Houston, Texas, United States
Endo Clinical Trial Site #1, McAllen, Texas, United States
Endo Clinical Trial Site #21, San Antonio, Texas, United States
Endo Clinical Trial Site #6, San Antonio, Texas, United States
Endo Clinical Trial Site #18, Salt Lake City, Utah, United States
Endo Clinical Trial Site #26, Lynchburg, Virginia, United States
Endo Clinical Trial Site #37, Midlothian, Virginia, United States
Endo Clinical Trial Site #11, Suffolk, Virginia, United States
Name: Nina Green
Affiliation: Endo Pharmaceuticals
Role: STUDY_DIRECTOR